Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Brookline Bancorp Inc is a banks-regional business based in the US. Brookline Bancorp shares (BRKL) are listed on the NASDAQ and all prices are listed in US Dollars. Brookline Bancorp employs 780 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$15.44|
|52-week range||$8.94 - $17.01|
|50-day moving average||$14.96|
|200-day moving average||$15.27|
|Wall St. target price||$17.75|
|Dividend yield||$0.47 (3.03%)|
|Earnings per share (TTM)||$1.31|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||-0.45%|
|1 month (2021-09-21)||9.89%|
|3 months (2021-07-21)||11.40%|
|6 months (2021-04-21)||15.44|
|1 year (2020-10-21)||62.01%|
|2 years (2019-10-21)||0.98%|
|3 years (2018-10-19)||15.64|
|5 years (2016-10-21)||21.10%|
Valuing Brookline Bancorp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Brookline Bancorp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Brookline Bancorp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Brookline Bancorp shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Brookline Bancorp's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.38. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Brookline Bancorp's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$297.2 million|
|Operating margin TTM||48.19%|
|Gross profit TTM||$222.9 million|
|Return on assets TTM||1.18%|
|Return on equity TTM||10.89%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
There are currently 1.5 million Brookline Bancorp shares held short by investors – that's known as Brookline Bancorp's "short interest". This figure is 20.2% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting Brookline Bancorp shares can be evaluated.
Brookline Bancorp's "short interest ratio" (SIR) is the quantity of Brookline Bancorp shares currently shorted divided by the average quantity of Brookline Bancorp shares traded daily (recently around 319598.92008639). Brookline Bancorp's SIR currently stands at 4.63. In other words for every 100,000 Brookline Bancorp shares traded daily on the market, roughly 4630 shares are currently held short.
However Brookline Bancorp's short interest can also be evaluated against the total number of Brookline Bancorp shares, or, against the total number of tradable Brookline Bancorp shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Brookline Bancorp's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Brookline Bancorp shares in existence, roughly 20 shares are currently held short) or 0.0195% of the tradable shares (for every 100,000 tradable Brookline Bancorp shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Brookline Bancorp.
Find out more about how you can short Brookline Bancorp stock.
Dividend payout ratio: 35.61% of net profits
Recently Brookline Bancorp has paid out, on average, around 35.61% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.11% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Brookline Bancorp shareholders could enjoy a 3.11% return on their shares, in the form of dividend payments. In Brookline Bancorp's case, that would currently equate to about $0.47 per share.
While Brookline Bancorp's payout ratio might seem fairly standard, it's worth remembering that Brookline Bancorp may be investing much of the rest of its net profits in future growth.
Brookline Bancorp's most recent dividend payout was on 26 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 August 2021 (the "ex-dividend date").
Brookline Bancorp's shares were split on a 2187:1000 basis on 9 July 2002. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 2187 shares. This wouldn't directly have changed the overall worth of your Brookline Bancorp shares – just the quantity. However, indirectly, the new 54.3% lower share price could have impacted the market appetite for Brookline Bancorp shares which in turn could have impacted Brookline Bancorp's share price.
Over the last 12 months, Brookline Bancorp's shares have ranged in value from as little as $8.944 up to $17.0055. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Brookline Bancorp's is 0.7328. This would suggest that Brookline Bancorp's shares are less volatile than average (for this exchange).
Brookline Bancorp, Inc. operates as a bank holding company for the Brookline Bank that provide commercial, business, and retail banking services to corporate, municipal, and retail customers in the United States. Its deposit products include non-interest-bearing demand checking, NOW, savings, and money market accounts. The company's loan portfolio primarily comprises first mortgage loans secured by commercial, multi-family, and residential real estate properties; loans to business entities comprising commercial lines of credit; loans to condominium associations; loans and leases for equipment financing for small businesses; financing for construction and development projects; and home equity and other consumer loans. It also provides term loans, letters of credit, foreign exchange, cash management, investment advisory, and online and mobile banking services, as well as invests in debt and equity securities. As of December 31, 2020, the company operated 50 full-service banking offices in greater Boston, the north shore of Massachusetts, and Rhode Island. Brookline Bancorp, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.